Cargando…

Dissolution Assay of Bupropion/Naltrexone Hydrochloride Salts of Bilayer Composition Tablets Following the Development and Validation of a Novel HPLC Method

Compounded medicinal products containing bupropion hydrochloride (BUP·HCl) and naltrexone hydrochloride (NTX·HCl) are available as adjunct therapy for the management of weight in obese/overweight adults. The present work describes the development and validation of a novel RP-HPLC method for a simult...

Descripción completa

Detalles Bibliográficos
Autores principales:	Apostolidi, Anna, Protopapa, Chrystalla, Siamidi, Angeliki, Vlachou, Marilena, Dotsikas, Yannis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9739382/ https://www.ncbi.nlm.nih.gov/pubmed/36499947 http://dx.doi.org/10.3390/ma15238451

Ejemplares similares

Probing the Release of Bupropion and Naltrexone Hydrochloride Salts from Biopolymeric Matrices of Diverse Chemical Structures
por: Siamidi, Angeliki, et al.
Publicado: (2021)

Excipients Used for Modified Nasal Drug Delivery: A Mini-Review of the Recent Advances
por: Protopapa, Chrystalla, et al.
Publicado: (2022)

Naltrexone/Bupropion: Contrave®; Naltrexone SR/Bupropion SR
Publicado: (2012)

Design and Development of Low- and Medium-Viscosity Alginate Beads Loaded with Pluronic(®) F-127 Nanomicelles
por: Kalogeropoulou, Flora, et al.
Publicado: (2023)

Comparative In Vitro Controlled Release Studies on the Chronobiotic Hormone Melatonin from Cyclodextrins-Containing Matrices and Cyclodextrin: Melatonin Complexes
por: Vlachou, Marilena, et al.
Publicado: (2017)

Use of Contrave, Naltrexone with Bupropion, Bupropion, or Naltrexone and Major Adverse Cardiovascular Events: A Systematic Literature Review
por: Dahlberg, Sarah, et al.
Publicado: (2022)

Modified Release of the Pineal Hormone Melatonin from Matrix Tablets Containing Poly(L-lactic Acid) and Its PLA-co-PEAd and PLA-co-PBAd Copolymers
por: Vlachou, Marilena, et al.
Publicado: (2022)

Development and Characterization of Eudragit(®)-Based Electrospun Nanofibrous Mats and Their Formulation into Nanofiber Tablets for the Modified Release of Furosemide
por: Vlachou, Marilena, et al.
Publicado: (2019)

Simultaneous determination of naltrexone and bupropion in their co-formulated tablet utilizing green chromatographic approach with application to human urine
por: Abdel-Gawad, Sherif A., et al.
Publicado: (2018)

Melatonin/Cyclodextrin Inclusion Complexes: A Review
por: Sakellaropoulou, Aikaterini, et al.
Publicado: (2022)

Effect of combined naltrexone and bupropion therapy on the brain’s functional connectivity
por: Wang, Gene-Jack, et al.
Publicado: (2018)

Electroencephalographic and behavioral convulsant effects of hydrobromide and hydrochloride salts of bupropion in conscious rodents
por: Henshall, David C, et al.
Publicado: (2009)

RP-HPLC Estimation of Imipramine Hydrochloride and Diazepam in Tablets
por: Srikantha, D., et al.
Publicado: (2015)

Determination of Bupropion and Its Impurities via a Chaotropic Chromatography Method Following Analytical Quality-by-Design Principles for Method Development
por: Gkountanas, Kostas, et al.
Publicado: (2022)

Effect of combined naltrexone and bupropion therapy on the brain's reactivity to food cues
por: Wang, G-J, et al.
Publicado: (2014)

Formulation and evaluation of bilayer tablet for bimodal release of venlafaxine hydrochloride
por: Momin, Munira M., et al.
Publicado: (2015)

3D-Printed Oral Dosage Forms: Mechanical Properties, Computational Approaches and Applications
por: Karalia, Danae, et al.
Publicado: (2021)

Recent Advances in the Excipients Used for Modified Ocular Drug Delivery
por: Koutsoviti, Melitini, et al.
Publicado: (2021)

Recent Advances in the Excipients Used in Modified Release Vaginal Formulations
por: Dedeloudi, Aikaterini, et al.
Publicado: (2022)

RP-HPLC Estimation of Venlafaxine Hydrochloride in Tablet Dosage Forms
por: Baldania, S. L., et al.
Publicado: (2008)

Naltrexone and Bupropion Combination Treatment for Smoking Cessation and Weight Loss in Patients With Schizophrenia
por: Lyu, Xuechan, et al.
Publicado: (2018)

RP – HPLC method for the estimation of Tamsulosin Hydrochloride in Tablet Dosage Form
por: Kumari, Richa, et al.
Publicado: (2010)

Development and Validation of RP-HPLC Method for the Estimation of Ivabradine Hydrochloride in Tablets
por: Seerapu, Sunitha, et al.
Publicado: (2010)

Determination of Montelukast Sodium and Bambuterol Hydrochloride in Tablets using RP HPLC
por: Patil, Smita, et al.
Publicado: (2009)

Naltrexone sustained-release/bupropion sustained-release for the management of obesity: review of the data to date
por: Caixàs, Assumpta, et al.
Publicado: (2014)

Effects of topiramate, bupropion and naltrexone isolated or combined on subcutaneous adipose tissue in obese rats
por: Scudeler, Monica Alhadas, et al.
Publicado: (2022)

The relationship between early weight loss and weight loss maintenance with naltrexone-bupropion therapy
por: le Roux, Carel W., et al.
Publicado: (2022)

Simultaneous RP-HPLC Estimation of Trifluoperazine Hydrochloride and Chlordiazepoxide in Tablet Dosage Forms
por: Patel, Sejal K., et al.
Publicado: (2009)

HPLC Method for Estimation of Metformin Hydrochloride in Formulated Microspheres and Tablet Dosage Form
por: Kar, Mousumi, et al.
Publicado: (2009)

RP-HPLC Method for Simultaneous Estimation of Frusemide and Amiloride Hydrochloride in Tablet Formulation
por: Nagori, B. P., et al.
Publicado: (2010)

Naltrexone HCI/bupropion HCI for chronic weight management in obese adults: patient selection and perspectives
por: Tek, Cenk
Publicado: (2016)

Naltrexone/Bupropion extended release‐induced weight loss is independent of nausea in subjects without diabetes
por: Hong, K., et al.
Publicado: (2016)

Convulsive liability of bupropion hydrochloride metabolites in Swiss albino mice
por: Silverstone, Peter H, et al.
Publicado: (2008)

Liquid chromatographic determinations of meta-chlorobenzoic acid in bupropion hydrochloride
por: Sinha, Sukumar, et al.
Publicado: (2013)

Formulation and In Vitro Evaluation of Bilayer Tablets of Nebivolol Hydrochloride and Nateglinide for the Treatment of Diabetes and Hypertension
por: Ryakala, Harika, et al.
Publicado: (2015)

Pineal hormone melatonin as an adjuvant treatment for COVID-19 (Review)
por: Vlachou, Marilena, et al.
Publicado: (2021)

Environmental impacts due to the use of sunscreen products: a mini-review
por: Chatzigianni, Myrto, et al.
Publicado: (2022)

Dissolution Profile Evaluation of Eight Brands of Metformin Hydrochloride Tablets Available in Jimma, Southwest Ethiopia
por: Umeta, Belachew, et al.
Publicado: (2021)

Simultaneous RP-HPLC and HPTLC Estimation of Fluoxetine Hydrochloride and Olanzapine in Tablet Dosage Forms
por: Patel, Sejal, et al.
Publicado: (2009)

Letter to the editor: naltrexone sustained-release/bupropion sustained-release for the management of obesity: review of the data to date
por: Buehler, Anna M
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_pkabmmrr3obn5hb63pvvhrbquu